20434 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines Non-condensed oxazines and containing further heterocyclic rings
Anti-Giardial Compounds
#2COMPOUND USED AS INHIBITOR OF CDK4 KINASE AND USE THEREOF
#3METHODS FOR DETECTING AND TREATING IDIOPATHIC PULMONARY FIBROSIS
#4PHARMACEUTICAL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF TREATING DEPRESSION AND OTHER DISORDERS
#5AZAQUINAZOLINE PAN-KRAS INHIBITORS
#6DOSING OF KRAS INHIBITOR FOR TREATMENT OF CANCERS
#7CBL-B INHIBITORS AND ANTI-PD1/ANTI-PD-L1 FOR USE IN THE TREATMENT OF CANCER
#8CANNABICYCLOL DERIVATIVES AND PREPARATION METHODS THEREOF
#9SUBSTITUTED FUROPYRIDINES FOR THERAPEUTIC USE
#10BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF
#11A FREEZE-DRYING PROCESS FOR AN ADC
#12PRECISION THERAPY FOR THE TREATMENT OF CANCER
#13NTSR1-TARGETED RADIOPHARMACEUTICALS AND DNA DAMAGE RESPONSE INHIBITOR COMBINATION THERAPY
#14COMBINATIONS OF ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND CHEMOTHERAPEUTIC AGENTS, AND METHODS OF USE
#15CBL-B INHIBITOR, COMPOSITIONS COMPRISING A CBL-B INHIBITOR IN A METHOD OF TREATING A DISEASE ASSOCIATED WITH CELL PROLIFERATION
#16LINEZOLID FORMULATIONS
#17METHOD OF TREATING PAIN OR INTERSTITIAL CYSTITIS USING INDOLE COMPOUND
#18COMBINATION THERAPY FOR TREATING CANCER
#19Mutant Pi3k-Alpha Inhibitors And Their Use As Pharmaceuticals
#20QUINOLINE DERIVATIVES
#21N-(5-SUBSTITUTED-[(1,3,4-THIADIAZOLYL) OR (THIAZOLYL)])(SUBSTITUTED)CARBOXAMIDE COMPOUNDS AND USE THEREOF FOR INHIBITING HUMAN POLYMERASE THETA
#22ARYL OR HETEROARYL DERIVATIVE, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF KINASE-RELATED DISEASES
#23TARGETING IMMUNE SUPPRESSION AFTER ATR INHIBITION
#24DOSING OF KRAS INHIBITOR FOR TREATMENT OF CANCERS
#25IRHOM2 INHIBITORS AND USES THEREOF
#26THERAPEUTIC COMPOUNDS
#27QUATERNARY AMMONIUM CATION SUBSTITUTED COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS
#28METHODS FOR TREATING NEUROGENERATIVE DISEASES
#29SMALL MOLECULE INHIBITORS OF LACTATE DEHYDROGENASE AND METHODS OF USE THEREOF
#30COMPOSITIONS FOR PREVENTING OR TREATING CHARCOT-MARIE-TOOTH DISEASE (CMT)
#31TRIPLE COMBINATION FORMULATIONS FOR ANTIEMETIC THERAPY
#32FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF
#33PHENYL UREA DERIVATIVE
#34MODULATORS OF THE INTEGRATED STRESS PATHWAY
#35METHOD FOR DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDER ON BASIS OF ACTIVITY REGULATION MECHANISM OF DORMANT NEURAL STEM CELL
#36METHODS OF USE OF MODULATORS TO IMPROVE NERVE REGENERATION
#37DISULFIDE CONTAINING THERAPEUTICS
#38PRMT5 INHIBITORS AND USES THEREOF
#39LARGE-CONDUCTANCE POTASSIUM CHANNEL MODULATORS, COMPOSITIONS THEREOF, METHODS OF MANUFACTURING THEREOF, AND METHODS OF USE THEREOF
#40IMIDAZOLE-CONTAINING CONDENSED RING DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN MEDICINE
#41New (Homo)Piperidinyl Heterocycles as Sigma Ligands
#42BENZAMIDE COMPOUNDS
#43EP300/CBP MODULATOR, PREPARATION METHOD THEREFOR AND USE THEREOF
#44METHOD AND COMPOSITION FOR INDUCING TOLERANCE
#45METHODS FOR TREATING CANCER
#463-(4-((4-(MORPHOLINOMETHYL-BENZYL)OXY)-1 -OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS
#47TYPE I DIABETES THERAPY
#48USE OF ATR AND CHK1 INHIBITOR COMPOUNDS
#49COMPOSITIONS AND METHODS FOR TREATMENT OF PAIN
#50CDK Inhibitors And Their Use As Pharmaceuticals
#51COMBINATION OF A PROTEASOME INHIBITOR AND A HDAC INHIBITOR AND ITS USE FOR THE TREATMENT OF GENETIC DISEASES LINKED TO A PROTEIN CONFORMATIONAL DISORDER
#52COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS
#53Compound for the treatment and prophylaxis of a lipofuscin-associated disease and/or a disease associated with aged oxidized melanin
#54COMBINATIONS OF ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND CHEMOTHERAPEUTIC AGENTS, AND METHODS OF USE
#55LINEZOLID FORMULATIONS
#56Inhibitors of peptidylarginine deiminases
#57ENHANCEMENT OF CD47 BLOCKADE THERAPY BY PROTEASOME INHIBITORS
#58Quinoline derivatives
#591,2,4-triazine-4-amine derivatives
#60COMPOSITIONS AND METHODS FOR INCREASING CELL SURFACE OXYTOCIN RECEPTOR (OXTR)
#61Modulators of BCL6 proteolysis and associated methods of use
#62COMBINATION THERAPY FOR TREATING CANCER
#63Triple combination formulations for antiemetic therapy
#64LOW-DOSE BRIMONIDINE COMBINATIONS AND USES THEREOF
#65Benzamide compounds
#66Small molecule inhibitors of lactate dehydrogenase and methods of use thereof
#67PYRIDYLPYRIDONE COMPOUNDS
#68DISUBSTITUTED BENZOTHIENYL-PYRROLOTRIAZINES AND THEIR USE AS FGFR KINASE INHIBITORS
#69ANILINE-BASED WDR5 PROTEIN-PROTEIN INTERACTION INHIBITOR, AND PREPARATION METHOD AND USE THEREOF
#70METHODS FOR TREATING INTRACRANIAL HEMORRHAGE AND ASSESSING EFFICACY
#71CDK inhibitors and their use as pharmaceuticals
#72SUBSTITUTED PYRROLOPYRIDINE-DERIVATIVES
#733-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus
#74Aminoquinoline Derivatives and Uses Thereof
#75HPK1 INHIBITORS AND METHODS OF USING SAME
#76NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES
#77POTASSIUM CHANNEL MODULATORS
#78TREATMENT FOR VENETOCLAX-RESISTANT AND VENETOCLAX-SENSITIVE ACUTE MYELOID LEUKEMIA
#79Small molecule inhibitors of lactate dehydrogenase and methods of use thereof
#80Combination drug
#81Bifunctional molecules for targeting Rpn11
#82AZAINDOLE DERIVATIVES AS RHO-KINASE INHIBITORS
#83Methods and Compositions for Treatment of Cancer with PARP Inhibitors
#84Compositions and methods of use thereof for treatment of proteinopathies
#85Method of treating pain or interstitial cystitis using indole compound
#86USE OF ISATUXIMAB FOR THE TREATMENT OF RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
#87Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
#88Methods of using indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitors
#89Compounds and compositions for the treatment of parasitic diseases
#90Pyrimidine derivatives as PGE2 receptor modulators
#91METHODS OF TREATING TRANSPLANT REJECTION
#92Combination therapy for treating cancer
#93Methods for Detecting and Treating Idiopathic Pulmonary Fibrosis
#94Substituted amino triazoles useful as chitinase inhibitors
#95Benzamide compounds
#96Benzimidazole compounds and derivatives as EGFR inhibitors
#973-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus
#98Dosing of inhibitor for treatment of cancers
#99Linezolid formulations
#100Combination comprising at least one spliceosome modulator and at least one inhibitor chosen from BCL2 inhibitors, BCL2/BCLxL inhibitors, and BCLxL inhibitors and methods of use
#101Type I diabetes therapy
#102MODULATORS OF THE INTEGRATED STRESS PATHWAY
#103Benzamide compounds
#104Benzamide compounds
#105Anticancer treatment for uveal melanoma
#106Pyridylpyridone compounds
#107FORMULATIONS OF COPANLISIB
#108EZH2 inhibitor combination therapies
#109Inhibitors of protein kinases
#110HPK1 inhibitors and methods of using same
#111Triple combination formulations for antiemetic therapy
#112EPIGENETIC INHIBITORS FOR SENSITIZING HEMATOLOGIC OR OTHER MALIGNANCIES TO GLUCOCORTICOID THERAPY
#113Quinoline derivatives
#114Compositions and methods for drug sensitization of parasites
#1152-(substituted benzene matrix) aromatic formate FTO inhibitor, preparation method therefor, and applications thereof
#116RORC2 INHIBITORS AND METHODS OF USE THEREOF
#117STAT5a AND ITS FUNCTIONAL TUMOR SUPPRESSOR ANALOGS FOR TREATMENT OF MALIGNANCIES EXPRESSING NPM/ALK AND OTHER ONCOGENIC KINASES
#118SUBSTITUTED 4-METHYL-PYRROLO[1,2-A]PYRIMIDINE-8-CARBOXAMIDE COMPOUNDS AND USES THEREOF FOR MODULATING GLUCOCEREBROSIDASE ACTIVITY
#119Small molecule inhibitors of lactate dehydrogenase and methods of use thereof
#120A Pharmaceutical Composition Comprising An Oxazine Derivative And Its Use In The Treatment Or Prevention Of Alzheimer's Disease
#121COMBINATIONS OF AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND CHEMOTHERAPEUTIC AGENTS, AND METHODS OF USE
#122Potassium channel modulators
#123Intermediates useful in the synthesis of compounds as modulators of protein kinases
#124FGFR4 inhibitor, preparation method therefor, and applications thereof
#125Use of ATR and Chk1 inhibitor compounds
#1263-(4-((4-morpholinomethyl-benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus
#127COMPOSITION COMPRISING COMBINATION OF EPICATECHIN AND ANTI-CANCER COMPOUND
#128Methods and pharmaceutical compositions for the treatment of lung cancer
#129Enhancement of CD47 blockade therapy by proteasome inhibitors
#130Aminoheteroaryl benzamides as kinase inhibitors
#131Multifunctional inhibitors of MEK/PI3K and mTOR/MEK/PI3K biological pathways and therapeutic methods using the same
#132CDK1 inhibitors of acetyl chrysin mannich base derivatives, synthesis and use thereof
#133TOPICAL ANTIMICROBIAL COMPOSITIONS AND METHODS OF FORMULATING THE SAME
#134Substituted 4-methyl-pyrrolo[1,2-a]pyrimidine-8-carboxamide compounds and uses thereof for modulating glucocerebrosidase activity
#135RORC2 INHIBITORS AND METHODS OF USE THEREOF
#136Dimeric compounds
#137Substituted chromenones as modulators of protein kinases
#138Tyrosine kinase inhibitors for use in a method of treating cancer in association with a reduced caloric intake
#1392-amino-N-[7-methoxy-2, 3-dihydroimidazo-[1,2-c] quinazolin-5-yl] pyrimidine-5-carboxamides
#140Nitrogenous heterocyclic compound, preparation method, intermediate, composition and use
#141Heterocyclic compound
#142Biaryl derivative and medicine containing same
#1431,2,4-triazine-4-amine derivatives
#144AMIDO THIADIAZOLE DERIVATIVES AS NADPH OXIDASE INHIBITORS
#145Benzamide and nicotinamide compounds and methods of using same
#146DISUBSTITUTED BENZOTHIENYL-PYRROLOTRIAZINES AND THEIR USE AS FGFR KINASE INHIBITORS
#147LOW-DOSE BRIMONIDINE COMBINATIONS AND USES THEREOF
#148METHODS OF TREATING TRANSPLANT REJECTION
#149Substituted 4-methyl-pyrrolo[1,2-A]pyrimidine-8-carboxamide compounds and uses thereof for modulating glucocerebrosidase activity
#150Salt of EGFR inhibitor, crystalline form and uses thereof
#151Octahydropyrrolopyrroles their preparation and use
#152P38 MAP kinase inhibitors for wound healing
#153RORC2 INHIBITORS AND METHODS OF USE THEREOF
#154Small molecule inhibitors of lactate dehydrogenase and methods of use thereof
#155Nitric oxide-releasing prodrug molecule of substituted quinazolines
#156Potassium channel modulators
#157Inhibitors of protein kinases
#158Methods of using indazole-3-carb oxamides and their use as Wnt/B-catenin signaling pathway inhibitors
#159HPK1 inhibitors and methods of using same
#160Heterocyclic compound
#161Pharmacologically active compounds
#162Substituted chromenones as modulators of protein kinases
#163RORC2 INHIBITORS AND METHODS OF USE THEREOF
#164Substituted 4-methyl-pyrrolo[1,2-A]pyrimidine-8-carboxamide compounds and uses thereof for modulating glucocerebrosidase activity
#165Aminoheteroaryl benzamides as kinase inhibitors
#166Combined treatment with a TLR7 agonist and an HBV capsid assembly inhibitor
#167Combination drug
#168Ink composition, printed matter and printing method
#169Amido thiadiazole derivatives as NADPH oxidase inhibitors
#170Derivatives of 6-substituted triazolopyridazines as Rev-Erb agonists
#1711,2,4-triazine-4-amine derivatives
#172Compounds and methods for kinase modulation, and indications therefor
#173Noxious arthropod control agent containing amide compound
#174KINASE INHIBITORS
#175Aminoquinoline derivatives and uses thereof
#176Aminoheteroaryl benzamides as kinase inhibitors
#1773-(4-((4-morpholinomethyl-benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus
#178Asparagine endopeptidase (AEP) inhibitors for managing cancer and compositions related thereto
#179COMBINATION THERAPY
#180Carbazole compounds useful as bromodomain inhibitors
#181Rocuronium preparation with improved stability
#182STAT5a and its functional tumor suppressor analogs for treatment of malignancies expressing NPM/ALK and other oncogenic kinases
#183Methods for treating attention deficit hyperactivity disorder
#184Amido-substituted azole compounds
#185Substituted 4-methyl-pyrrolo[1,2-A]pyrimidine-8-carboxamide compounds and uses thereof for modulating glucocerebrosidase activity
#186Prostaglandin and vasoconstrictor pharmaceutical compositions and methods of use
#187Benzamide and nicotinamide compounds and methods of using same
#188Small molecule inhibitors of Mcl-1 and uses thereof
#189TREATMENT OF GASTROINTESTINAL AND OTHER DISORDERS
#190Pharmacologically active compounds
#191USP7 inhibitor compounds and methods of use
#192NOVEL COMPOUNDS AS RESPIRATORY STIMULANTS FOR TREATMENT OF BREATHING CONTROL DISORDERS OR DISEASES
#193Antiviral compounds
#194Inhibitors of histone demethylases
#1955-ALKYNYL-PYRIMIDINES
#196NEW BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOF
#197Compounds and methods for inhibiting histone demethylases
#198Inhibitors
#199Aminopyrimidine compounds as inhibitors of T790M containing EGFR mutants
#200Carbazole compounds useful as bromodomain inhibitors
#201NOVEL COMPOUNDS AND COMPOSITIONS FOR TREATMENT OF BREATHING CONTROL DISORDERS OR DISEASES
#202Pyridine compounds used as PI3 kinase inhibitors
#203Compounds as modulators of protein kinases
#204Sulfur-containing bicyclic compound
#205NOVEL OXAZINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE
#206Pyrimidinyl-pyridazinone derivatives for treating a disease which is influenced by inhibition of met kinase
#207Substituted pyrimidine compounds and their use as SYK inhibitors
#208Pyrrolopyridinone derivatives as TTX-S blockers
#209Inhibitors of protein kinases
#210Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
#211NOVEL BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOF
#212Aminoquinoline derivatives and uses thereof
#213Pyridazinone derivatives
#2141,2,4-triazine-4-amine derivatives
#215Compounds and compositions for treatment of breathing control disorders or diseases
#216NOVEL UREA AND THIOUREA DERIVATIVES
#217DISUBSTITUTED BENZOTHIENYL-PYRROLOTRIAZINES AND THEIR USE AS FGFR KINASE INHIBITORS
#218Carbazole compounds useful as bromodomain inhibitors
#219Pharmaceutical compounds
#220Pharmaceutically active disubstituted triazine derivatives
#221PIM kinase inhibitors and preparation methods and use in medicinal manufacture thereof
#222Pyrimidinyl pyridazinone derivatives
#223Ribosome structure and protein synthesis inhibitors
#224Inhibitors
#225Pharmaceutical combinations for the treatment of metabolic disorders
#226Inhibitors of protein kinases
#227Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
#228Compounds and Compositions for Treating Cancer
#229Pharmaceutical compounds
#230PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF METABOLIC DISORDERS
#231WOGONIN FOR THE PREVENTION AND THERAPY OF CARDIAC HYPERTROPHY
#232Pyridazinone derivatives
#233Pyridazinone derivatives
#234Oxazine derivatives and their use in the treatment of disease
#235Disubstituted benzothienyl-pyrrolotriazines and uses thereof
#236PHARMACEUTICALLY ACCEPTABLE MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND THEIR METHODS OF IDENTIFICATION
#237NEW BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOF
#238COMPOUNDS, PREPARATION AND USES THEREOF
#2391,2,4-triazine-4-amine derivatives
#240Therapeutic methods employing substituted piperidines which are CCR3 antagonists
#241Novel Compounds and Compositions for Treatment of Breathing Control Disorders or Diseases
#242Pyrimidinyl pyridazinone derivatives
#243Compounds as modulators of protein kinases
#244PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF METABOLIC DISORDERS
#245Methods for the treatment and prevention of ocular disorders
#246Compounds And Compositions For Treating Cancer
#247Compounds as respiratory stimulants for treatment of breathing control disorders or diseases
#248Inhibitors of protein kinases
#249Combinations of an anti-HER2 antibody-drug conjugate and chemotherapeutic agents, and methods of use
#250METHOD AND COMPOSITION USING A DUAL SPECIFICITY PROTEIN TYROSINE PHOSPHATASE AS AN ANTIMALARIAL DRUG TARGET
#2515-alkynyl-pyrimidines
#252Urea and thiourea derivatives
#253Treatment of lupus nephritis using laquinimod
#254Oxazolidinones for the Treatment of Inflammatory Conditions of the Gastrointestinal Tract
#255Benzimidazoles and related analogs as sirtuin modulators
#256RAPAMYCIN ANALOGS AS ANTI-CANCER AGENTS
#257Inhibitors
#258STAT5a and its functional tumor suppressor analogs for treatment of malignancies expressing NPM/ALK and other oncogenic kinases
#259Pharmaceutical compounds
#260Ribosome Structure and Protein Synthesis Inhibitors
#261Cyclic progestin regimens and kits
#262Substituted piperidines as CCR3 antagonists
#263Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
#264Use of Strobilurins for the Treatment of Disorders of Iron Metabolism
#265Pyridazinone derivatives
#266Ribosome structure and protein synthesis inhibitors
#267Pyrimidinyl pyridazinone derivatives
#268MICROANGIOPATHY TREATMENT AND PREVENTION
#269Method for identifying protein synthesis inhibitors by ribosome structure
#270Carboline derivatives useful in the inhibition of angiogenesis
#271METHODS FOR TREATING COGNITIVE DISORDERS USING 1-ARYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES, 1-HETEROARYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES AND RELATED COMPOUNDS
#272Method for the treatment and prevention of ocular disorders
#273AMINOTHIAZOLE DERIVATIVES AS INHIBITORS OF MARK
#274Inhibitors of protein kinases
#275Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease
#276Methods of using IGFIR and ABL kinase modulators
#277Carboline derivatives useful in the inhibition of angiogenesis
#278Use of LHRH antagonists for intermittent treatments
#279Synergistic compositions for treating HIV-1
#280Organic compounds
#281USE OF ACETYLATED OR ESTERIFICATED AZACYTIDINE, DECITABINE, OR OTHER NUCLEOSIDE ANALOGS AS ORAL AGENTS FOR THE TREATMENT OF TUMORS OR OTHER DYSPLASTIC SYNDROMES SENSITIVE TO HYPOMETHYLATING AGENTS
#282Combinations of Pyrazole Kinase Inhibitors and Further Antitumor Agents
#283Phenylalkynes
#284Phenylalkynes
#285Derivatives of [6,7-dihydro-5-imidazo[1,2-α]imidazole-3-sulfonylamino]-propionamide
#286Pharmaceutical compounds
#287Modulators of muscarinic receptors
#288Medicaments Comprising Carbonyl Compounds, And The Use Thereof
#289Carboline Derivatives Useful in the Inhibition of Angiogenesis
#290Use of C-Kit Inhibitors for Treating Fibrosis
#291Substituted Arylpyrazines
#292Method of inhibiting FLT3 kinase
#293Cynnamyl alcohol derivative compounds and drugs containing the compounds as active ingredient
#294Phenylalkynes
#295Combination of a glycine/nmda antagonist and a tachykinin nk-1 receptor antagonist for use in the treatment of neurodegeneration
#296Methods of treating hyperproliferative cell disorders
#297Phenylalkynes
#298MODULATORS OF RIBOSOMAL FUNCTION AND IDENTIFICATION THEREOF
#299Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof
#300Cyclic progestin regimens and kits